1. Home
  2. NOAH vs ALT Comparison

NOAH vs ALT Comparison

Compare NOAH & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOAH
  • ALT
  • Stock Information
  • Founded
  • NOAH 2005
  • ALT 1997
  • Country
  • NOAH China
  • ALT United States
  • Employees
  • NOAH N/A
  • ALT N/A
  • Industry
  • NOAH Investment Managers
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • NOAH Finance
  • ALT Health Care
  • Exchange
  • NOAH Nasdaq
  • ALT Nasdaq
  • Market Cap
  • NOAH 559.3M
  • ALT 472.3M
  • IPO Year
  • NOAH 2010
  • ALT N/A
  • Fundamental
  • Price
  • NOAH $8.46
  • ALT $4.55
  • Analyst Decision
  • NOAH Hold
  • ALT Strong Buy
  • Analyst Count
  • NOAH 3
  • ALT 8
  • Target Price
  • NOAH $12.50
  • ALT $21.00
  • AVG Volume (30 Days)
  • NOAH 148.3K
  • ALT 2.2M
  • Earning Date
  • NOAH 05-28-2025
  • ALT 05-08-2025
  • Dividend Yield
  • NOAH 25.06%
  • ALT N/A
  • EPS Growth
  • NOAH N/A
  • ALT N/A
  • EPS
  • NOAH 0.92
  • ALT N/A
  • Revenue
  • NOAH $356,342,836.00
  • ALT $20,000.00
  • Revenue This Year
  • NOAH N/A
  • ALT N/A
  • Revenue Next Year
  • NOAH $7.59
  • ALT N/A
  • P/E Ratio
  • NOAH $9.15
  • ALT N/A
  • Revenue Growth
  • NOAH N/A
  • ALT N/A
  • 52 Week Low
  • NOAH $7.14
  • ALT $3.55
  • 52 Week High
  • NOAH $15.44
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • NOAH 35.58
  • ALT 43.21
  • Support Level
  • NOAH $8.27
  • ALT $4.32
  • Resistance Level
  • NOAH $9.09
  • ALT $4.75
  • Average True Range (ATR)
  • NOAH 0.55
  • ALT 0.38
  • MACD
  • NOAH -0.01
  • ALT 0.05
  • Stochastic Oscillator
  • NOAH 35.43
  • ALT 63.22

About NOAH Noah Holdings Limited

Noah Holdings Ltd is a wealth management service provider. It focuses on wealth investment and asset allocation services for high-net-worth individuals and enterprises in China. The company operates through three segments: wealth management, asset management, and other business. Its product offerings consisting of over-the-counter wealth management and OTC asset management products and mutual fund products. The portfolio of the group mostly includes fixed income products, private equity funds and securities investment funds. Majority of the firm revenue is generated through one-time commissions and recurring service fees paid by third-party product providers.

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

Share on Social Networks: